Prasad Koparkar of CRISIL expects India Inc revenue growth at around 10-12 percent for FY14. He continues to remain bullish on pharma and expect positive surprises going ahead.
first published: Jul 5, 2013 03:00 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell
Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live
Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live
Nifty Back Above 26,000 As IT Stocks Sprint Ahead; Nvidia Earnings In Focus| Closing Bell Live
